Does LABETALOL Cause Mobility decreased? 27 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Mobility decreased have been filed in association with LABETALOL (LABETALOL HYDROCHLORIDE). This represents 2.1% of all adverse event reports for LABETALOL.
27
Reports of Mobility decreased with LABETALOL
2.1%
of all LABETALOL reports
0
Deaths
27
Hospitalizations
How Dangerous Is Mobility decreased From LABETALOL?
Of the 27 reports, 27 (100.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LABETALOL. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does LABETALOL Cause?
Maternal exposure during pregnancy (252)
Foetal exposure during pregnancy (223)
Premature baby (189)
Drug ineffective (188)
Exposure during pregnancy (143)
Premature delivery (128)
Low birth weight baby (117)
Hypotension (86)
Hypertension (84)
Completed suicide (71)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LABETALOL Alternatives Have Lower Mobility decreased Risk?
LABETALOL vs LABETALOL\LABETALOL
LABETALOL vs LACIDIPINE
LABETALOL vs LACOSAMIDE
LABETALOL vs LACTOBACILLUS ACIDOPHILUS
LABETALOL vs LACTOBACILLUS RHAMNOSUS